In this study, a somatic in-frame deletion, p.(Gln58_Glu62del), in MAP2K1 was identified in FCD type I. Germline variants of MAP2K1 have been reported in patients with RASopathy, such as cardio-facio-cutaneous syndrome [27]. This evidence concerns the gene MAP2K1 and cardiofaciocutaneous syndrome.